2024 Update in Hematology and Medical Oncology — On Demand

Overview

The 2024 Update in Hematology and Medical Oncology — On Demand delivers comprehensive, on-demand continuing education focused on the latest advances in diagnosis, staging, and treatment of hematologic and solid tumor cancers. This expertly curated board review is designed to reinforce clinical expertise and support exam preparation for professionals in hematology and medical oncology.

On-demand hematology and medical oncology education — accessible anytime, anywhere.

Agenda

This on-demand program presents a detailed syllabus covering a wide range of cancer types and hematologic conditions, featuring presentations by recognized experts in the field. Each topic includes video presentations and corresponding PDF materials to enhance learning.

• Colon Cancer — Leonard B Saltz, MD
• Melanoma — Michael Postow, MD
• Prostate Cancer — Susan Slovin, MD, PhD
• Kidney Cancer — Robert Motzer, MD
• Mesothelioma — Marjorie G Zauderer, MD
• Urothelial Cancer — Gopa Iyer, MD
• Testis Cancer — Darren Feldman, MD
• Uterine, Cervix, and Other GYN Cancers — Carol Aghajanian, MD
• Ovarian Cancer — Rachel Grisham, MD
• Breast Cancer: Surgery — Anita Mamtani, MD
• Breast Cancer: Radiation Therapy — Lior Braunstein, MD
• Genetics — Zsofia Stadler, MD
• Small Cell Lung Cancer — Noura Choudhury, MD, Assistant Attending
• Triple Negative Breast Cancer: (Neo)adjuvant and Metastatic — Rachel Sanford, MD
• HER2 Positive Breast Cancer: (Neo)adjuvant and Metastatic — Chau Dang, MD
• Hormone Receptor Positive Breast Cancer: (Neo)adjuvant and Metastatic — Devika Gajria, MD
• Carcinoma of Unknown Primary — Anna Mary Varghese, MD
• Hepatocellular Cancer and Cholangiocarcinoma — Ghassan K Abou-Alfa, MD, MBA, Professor
• Pancreatic and Neuroendocrine Cancer — Eileen M O’Reilly, MD
• Non Small Cell Lung Cancer — Gregory Riely, MD
• Head & Neck, Thyroid, and Non-Melanoma Skin Cancer — Lara Dunn, MD
• Anal and Rectal Cancer — Michael Foote, MD
• Esophageal and Gastric Cancer — David Ilson, MD, PhD
• CNS Tumors — Thomas Kaley, MD
• Sarcoma — Robert G Maki, MD, PhD, FACP, FASCO
• Infectious Disease — Susan Seo, MD
• Pharmacology — Mrinal Gounder, MD
• Acute Myeloid Leukemia (AML) — Eytan Stein, MD
• Low-Grade Non-Hodgkin Lymphoma (NHL) — Andrew D Zelenetz, MD, PhD
• Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) — Meghan C Thompson, MD
• Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL), and Burkitt Lymphoma (BL) — Paul A Hamlin, MD
• Hodgkin Lymphoma (HL) / T Cell — Alison Moskowitz, MD
• Auto/Allo — Gunjan Shah, MD, MS
• CAR T cells — Michael Scordo, MD
• Acute Lymphocytic Leukemia (ALL) — Jae Park, MD
• Myeloproliferative Neoplasms (MPN) — Raajit Rampal, MD, PhD
• Myelodysplastic (MDS) — Aaron D Goldberg, MD
• Chronic Myelogenous Leukemia (CML) — Michael Mauro, MD
• Myeloma / Amyloid — Malin Hulcrantz, MD
• Approach to The Bleeding Patient — Rekha Parameswaran, MD
• The Role of the New Direct Oral Anticoagulants in Practice — Simon Mantha, MD, MPH
• Clotting in Cancer — Jeffrey Zwicker, MD
• Thrombocytopenia, ITP, and Beyond — Cy R Wilkins, MD
• Sickle Cell Disease, Thalassemia — Susanna Curtis, MD, PhD

Objectives

At the conclusion of this on-demand program, learners will be able to:

• Define state-of-the-science in diagnosis, staging, and therapeutic management of solid tumor cancers and hematologic cancers.
• Discuss recent treatment advances in solid tumor and hematologic oncology and apply knowledge gained in modern clinical practice.
• Prepare for ABIM examinations in medical oncology and hematology.

Speakers

This program features presentations by leading experts in hematology and medical oncology, including physicians with subspecialty expertise across a broad spectrum of cancers and hematologic disorders. Faculty disclosures relevant to financial relationships are available for review as part of the course materials.

Target Audience

This course is intended for hematologists, medical oncologists, oncology fellows, hematology-oncology advanced practice providers, and other healthcare professionals seeking to update their clinical knowledge and prepare for board examinations in the fields of hematology and medical oncology.

Why This Topic Matters

The 2024 Update in Hematology and Medical Oncology — On Demand addresses the rapidly evolving diagnostic and treatment landscape in oncology and hematology, supporting clinicians in maintaining up-to-date expertise. This resource from MedHub Central serves as a vital reference for applying current evidence-based strategies in specialized cancer care.

By integrating the latest clinical advances and research findings, this course reinforces professional competence and confidence in managing complex hematologic and solid tumor malignancies. The on-demand format ensures flexible access, allowing clinicians to engage with content aligned to hematology and medical oncology practice needs.